We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$19.6B
AUM Growth
-$348M
Cap. Flow
-$808M
Cap. Flow %
-4.12%
Top 10 Hldgs %
23.24%
Holding
803
New
87
Increased
323
Reduced
272
Closed
66

Sector Composition

Rank Sector Weight
1 Financials 28.77%
2 Energy 13.54%
3 Industrials 9.89%
4 Healthcare 9.09%
5 Technology 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
801
DELISTED
Allergan Inc
AGN
-38,940
Closed -$6.94M

Similar funds

Mackenzie Financial's Q4 2014 Portfolio in Review

As of Q4 2014, Mackenzie Financial held 803 positions worth $19.6B, down 1.7% from $19.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial withdrew a net $808M in Q4 2014, closing 66 positions and reducing 272 holdings. Its most notable exit was Edwards Lifesciences, an estimated $63.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Energy and Industrials.

Against the trend, Mackenzie Financial opened a new position in Rowan Companies Plc worth $135M.

  • Mackenzie Financial's largest Q4 2014 buy was Rowan Companies Plc: 5,773,997 shares worth $135M.
  • Mackenzie Financial added most to Transocean in Q4 2014, an estimated $105M increase.
  • Mackenzie Financial's biggest Q4 2014 reduction was Ovintiv, cutting an estimated $238M.
  • Mackenzie Financial fully exited Edwards Lifesciences in Q4 2014, selling an estimated $63.5M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $19.6B portfolio in Q4 2014.
  • Mackenzie Financial opened 87 new positions and closed 66 in Q4 2014.
  • Mackenzie Financial's portfolio value fell 1.7% quarter-over-quarter to $19.6B.

Based on Mackenzie Financial's 13F filing for Q4 2014, filed 11 Feb 2015.